Also, the proportion of Grz B-expressing CD8+ T-cells is higher in patients with mild symptoms than in those with severe symptoms, and Grz B is more effective in defending against the early stage of virus infection [64]. The gene discussed is CD8A; the disease is viral infectious disease.